Botox Receives Approval to Treat Migraines in U.K.

Published July 10, 2010

Botox Receives Approval to Treat Migraines in U.K.
Allergan Inc. won regulatory clearance in the U.K. for its wrinkle-smoothing Botox, an injectable drug, to be used as a treatment for migraines.
Read more on BusinessWeek

Fall in Heroin Deaths Obscures Importance of Addiction Treatment
A new study by Roosevelt University’s Illinois Consortium on Drug Policy shows deaths from heroin overdoses in Chicago’s Cook County fell 16 percent during the last decade, but the Chicago metropolitan region still ranks among the worst in the nation for heroin use.
Read more on PR Newswire via Yahoo! Finance

Cyclacel Pharma gets orphan drug status for sapacitabine to treat AML & MDS
Cyclacel Pharmaceuticals, Inc, a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to the company’s sapacitabine (CYC682) product candidate for the treatment of both acute myeloid leukaemia …
Read more on PharmaBiz